Catheter Precision (VTAK) Non Operating Investment Income (2026)
Catheter Precision's (VTAK) quarterly Non Operating Investment Income came in at $378000.0 in Q2 2026.
Powered by 
Analysis
Catheter Precision (VTAK) Non Operating Investment Income (2026) Analysis & Trends
Catheter Precision (VTAK) has reported Non Operating Investment Income for 1 consecutive years, with $378000.0 the latest figure, recorded in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Catheter Precision | 480,427.59 | -1.36 Mn | 98,000.00 | 378,000.00 |